Arkolith/Insider Trading/SLDB/Form 4

Herzich Paul

Chief Technology OfficerSolid Biosciences Inc. (SLDB) · full profile →Form 4 · filed Feb 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)4K$5.82$21K73K
Feb 13, 2026Option exercise(M)7K——76K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2026Option exercise(M)7K—$014K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-057865) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML